Drug Database
HU

Human recombinant interferon beta-1a (Megavex)

✓ Approved

AMEGA Biotech · IFNB1 · 重组蛋白

什么是 Human recombinant interferon beta-1a?

Human recombinant interferon beta-1a 是一种重组蛋白,由AMEGA Biotech研发。该药已获批,用于治疗相关适应症,给药途径:Intramuscular (IM) Injection。

药物档案

商品名Megavex
公司AMEGA Biotech
药物类别重组蛋白
分子靶点IFNB1
给药途径Intramuscular (IM) Injection
状态Approved

作用机制

分子靶点

Human recombinant interferon beta-1a 作用于 1 个分子靶点:

IFNB1interferon beta 1 (IFN-beta, IFNB)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

Human recombinant interferon beta-1a 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersMultiple sclerosis✓ Approved

相关研究文献

PubMedBMC microbiology2026-11-19

Secretory expression of mature recombinant elafin in Pichia pastoris and assessment of its in vitro antibacterial and antifungal effects.

Mokhtari Somayeh S, Lohrasbi-Nejad Azadeh A, Torkzadeh-Mahani Masoud M, Zolala Jafar J

Elafin is a small human host-defense peptide derived from trappin-2/pre-elafin, known for its antiprotease and anti-inflammatory functions. However, direct comparative evidence on the antimicrobial activity of mature recombinant elafin, particularly against fungal organisms, remains limited. This study aimed to produce secreted mature recombinant elafin in Pichia pastoris X-33 and comparatively assess its antimicrobial activity in vitro against Escherichia coli ATCC 25,922, Pseudomonas aeruginosa ATCC 15,442, Staphylococcus aureus ATCC 29,737, and Candida albicans ATCC 10,231 using agar well diffusion, viable-count assays, broth microdilution, and minimum bactericidal/minimum fungicidal concentration (MBC/MFC) determination. The elafin insert was cloned into pPICZαA, and positive P. pastoris transformants were confirmed by colony PCR. Elafin was secreted into the culture medium, and the 66 h post-induction supernatant was selected for purification based on SDS-PAGE detection of a low-molecular-weight band in the expected size range. Purification resulted in a low-molecular-weight His-tagged recombinant product with migration consistent with the expected size of the designed elafin construct. In agar well diffusion assays, recombinant elafin produced inhibition zones of 32, 28, 25, and 22 mm for E. coli, P. aeruginosa, C. albicans, and S. aureus, respectively. Viable-count assays showed concentration- and time-dependent but modest reductions in recoverable cells, with all reductions remaining below 1 log₁₀ and the greatest effect observed at 62 µg/mL after 6 h. The minimum inhibitory concentration (MIC) values were 31 µg/mL for E. coli, P. aeruginosa, and C. albicans, and 62 µg/mL for S. aureus. The MBC values were 62 µg/mL for E. coli and P. aeruginosa, 124 µg/mL for S. aureus, and the MFC for C. albicans was 62 µg/mL. This study demonstrates the secretory expression and purification of a low-molecular-weight His-tagged recombinant product consistent with the designed mature elafin construct in P. pastoris. The purified peptide exhibited measurable in vitro inhibitory activity under defined assay conditions, supporting further evaluation of recombinant elafin in broader microbial and physiological models.

PMID 43052731
阅读全文 →
PubMedWorld journal of psychiatry2026-11-19

Correction to: KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer's disease.

Lu Qun-Shan QS, Ma Lin L, Jiang Wen-Jing WJ, Wang Xing-Bang XB et al.

[This corrects the article DOI: 10.5498/wjp.v14.i3.445.][This corrects the article on p. 445 in vol. 14, PMID: 38617985.].

PMID 43053753
阅读全文 →
PubMedEye (London, England)2026-11-19

Coffee saucer grading system: a novel method for stratifying corneal trauma in the International Globe and Adnexal Trauma Epidemiology Study (IGATES) registry.

Cifuentes-González Carlos C, See Aedann A, Liu Renee R, Song Xin Ying Rachel XYR et al.

Ophthalmic trauma represents a leading cause of monocular blindness. Corneal injuries constitute a substantial subset of open globe injuries (OGIs), yet existing classifications insufficiently capture their anatomical heterogeneity. This study evaluated the prognostic utility of the Coffee Saucer Grading (CSG) system for stratifying corneal trauma and distinguishing subzone-specific visual outcomes and complications. This retrospective study analysed corneal OGIs across 12 countries within the International Globe and Adnexal Trauma Epidemiology Study (IGATES) registry. Corneal OGIs were categorised into 4 CSG subzones: Zone 1A (central cornea), Zone 1B (paracentral cornea), Zone 1 C (limbal region), and Zone 1D (combined corneal-limbal involvement). Corrected distance visual acuity (CDVA), blindness (CDVA < 6/60), and ocular complications were compared across subzones. Among 3577 patients, 81.0% (n = 2897) were male, and the mean age was 31.6 years (SD 19.4). Zone 1A injuries were most common at 36.8% (n = 881), followed by Zone 1D at 25.0% (n = 599), Zone 1B at 23.0% (n = 550), and Zone 1C at 15.1% (n = 362). Mean initial and final CDVA were 1.6 and 1.2 LogMAR, respectively (p < 0.001). Visual outcomes, odds of blindness, and complication profiles varied by subzone (p < 0.001). Compared with Zone 1B, the odds of blindness were higher for Zone 1A (OR 1.68), 1C (OR 1.87), and 1D (OR 3.30) injuries (p < 0.001). Zone 1D injuries demonstrated the highest complication burden (p = 0.003). The CSG system identified distinct subzone-specific differences in visual outcomes and complications, demonstrating the prognostic relevance of corneal wound topography. This reproducible framework may facilitate standardised trauma phenotyping, risk stratification, and multicentre research.

PMID 43052411
阅读全文 →
PubMedNPJ vaccines2026-11-19

Influenza neuraminidase as adjuvanted protein or mRNA vaccine protects mice against influenza A and B virus challenge.

Portela Catani João Paulo JP, Smet Anouk A, Ysenbaert Tine T, Amelinck Laura L et al.

Neuraminidase (NA) is an underutilized influenza vaccine antigen despite its recognized contribution to protective immunity. Here, we compared the immunogenicity and protective potential of multiple NA antigens delivered as an adjuvanted recombinant tetrameric protein or as mRNA-LNP encoding full-length NA in naïve mice. Both vaccine types induced robust neuraminidase-inhibiting (NAI) antibody responses and conferred protection to mice challenged with antigenically homologous influenza A or B viruses. However, only immunization with NA-encoding mRNA-LNP protected against challenge with a heterologous HxN2 virus, whereas immunization with recombinant NA was associated with earlier onset of weight loss following heterologous HxN2 virus challenge. Passive transfer of immune serum revealed that protection induced by mRNA immunization can be transferred by serum, and that early onset of weight loss is not induced by recombinant NA-derived sera; on the contrary, partial protection is achieved. Finally, NAI assays against a panel of antigenically distinct HxN2 viruses showed similar breadth of inhibition.

PMID 43052397
阅读全文 →
PubMedBMC biotechnology2026-11-19

Enhanced extracellular invertase production in Bacillus subtilis by boosting synthesis and secretion in a suitable chassis cell.

Yao Dongbang D, Chen Yuanyuan Y, Que Longwei L, Qi Jiaru J et al.

Soybeans are an important agricultural product, but they contain a significant amount of raffinose, which can cause flatulence when fermented by intestinal microorganisms. Invertase InvDz13 from Microbacterium trichothecenolyticum can effectively hydrolyze raffinose in soybean into the prebiotic melibiose, improving the nutritional value and economic benefits of soybean derivatives. However, its low yield limits industrial applications. This study produced InvDz13 in Bacillus subtilis, resulting in a recombinant enzyme with the natural enzyme's excellent properties. The extracellular InvDz13 production in B. subtilis was enhanced by boosting synthesis and secretion in a suitable chassis cell. Various extracellular protease-deficient chassis cells were constructed, and it was found that Vpr and WprA enhance the extracellular InvDz13 activity. The recombinant InvDz13 production was further enhanced by sequentially engineering the promoter, screening the signal peptide, and regulating key elements in the secretion pathway. The recombinant strain WBSS142I4PA, constructed using the promoter PspoVG-PspoVG142 and signal peptide SPYomL, co-expressing signal peptide peptidases SppA, exhibited a 10.02-fold increase in extracellular InvDz13 activity in shake flasks. Notably, the extracellular InvDz13 activity of WBSS142I4PA in a 3-L fermenter reached 568.86 U/mL. To our knowledge, this is the highest recombinant expression level of an exogenous invertase in B. subtilis reported so far. This is the first study to express InvDz13 in B. subtilis and develop a novel multidimensional combinatorial strategy to enhance its extracellular production. This study provides a theoretical foundation for the large-scale application of InvDz13 in soybean processing and paves novel avenues for protein production in B. subtilis.

PMID 43052969
阅读全文 →
PubMedNature communications2026-11-19

Tumor-intrinsic PTPN12 suppresses anti-tumor immunity in colorectal cancer by restraining a dual epigenetic and cytoskeletal dsRNA sensing program.

Huo Yachang Y, Tian Yijun Y, Wang Dan D, Ping Yu Y et al.

Innate sensing of endogenous double-stranded RNA and the ensuing interferon response are crucial for the efficacy of immune checkpoint inhibition. Microsatellite stable colorectal cancer characteristically lacks this response, remaining immune-refractory with undefined intrinsic regulators. Here, through an in vivo clustered regularly interspaced short palindromic repeats screen, we identify PTPN12 as a physiological barrier that suppresses double-stranded RNA sensing and interferon response. TRIM28 was identified as a direct PTPN12 substrate here; PTPN12 removes phosphorylation at Y370 to stabilize repressive complexes and silence transposable elements, while concurrently rewiring the adhesive cytoskeleton to disrupt the spatially organization of cytosolic double-stranded RNA required for efficient innate sensing. Pharmacological inducible PTPN12 knockdown inhibits pre-established tumor growth and overcomes immunotherapy resistance in vivo, recapitulating PTPN12 ablation-induced massive double-stranded RNA accumulation. Our findings reveal a role for PTPN12 in coupling epigenetic silencing with cytoskeletal surveillance, suggesting potential strategies to augment anti-tumor immunity and overcome immunotherapy resistance in microsatellite stable colorectal cancer.

PMID 43052240
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Human recombinant interferon beta-1a